Insider Trading March 27, 2026

CSB Bancorp Director Makes Small Purchase as Shares Hover Near 52-Week High

Director Cheryl M. Kirkbride adds to her stake with a $586 buy while CSBB trades near multi-month highs

By Avery Klein CSBB
CSB Bancorp Director Makes Small Purchase as Shares Hover Near 52-Week High
CSBB

CSB Bancorp, Inc. (OTC: CSBB) director Cheryl M. Kirkbride purchased 9.464 shares on March 24, 2026, paying $62.00 per share for a total outlay of $586. The transaction occurred as the stock trades close to its 52-week peak of $64.69. The company’s valuation metrics include a price-to-earnings ratio of 12.23, a dividend yield of 2.77%, and a market capitalization of $163 million. CSB Bancorp has increased its dividend for 12 consecutive years. After the purchase, Kirkbride’s direct ownership stands at 1,374.093 shares; she also holds additional indirect and spousal accounts. Reporting person disclaims beneficial ownership.

Key Points

  • Director Cheryl M. Kirkbride purchased 9.464 shares on March 24, 2026, at $62.00 per share, totaling $586.
  • After the transaction, Kirkbride directly owns 1,374.093 shares and additionally holds indirect positions: 2,255 shares via an IRA, 460 through a Spouse IRA, and 90 across spousal custodial accounts for children.
  • CSB Bancorp is trading near its 52-week high of $64.69 after a 44% gain over the past year and a 28% rise in the last six months; company metrics include a $163 million market cap, a P/E of 12.23, a 2.77% dividend yield, and 12 consecutive years of dividend increases.

CSB Bancorp, Inc. (OTC: CSBB) reported a director purchase on March 24, 2026, when Cheryl M. Kirkbride acquired 9.464 shares of common stock at a price of $62.00 per share. The total cost of the transaction was $586. The trade took place while the stock was trading close to its 52-week high of $64.69, following a 44% increase over the last year and a 28% advance in the past six months.

Following the acquisition, Kirkbride’s direct holdings of CSB Bancorp total 1,374.093 shares. In addition to that direct stake, she indirectly holds 2,255 shares via an IRA, 460 shares through a Spouse IRA, and 90 shares spread across various spousal custodial accounts for children. The reporting person disclaims beneficial ownership.

The company’s headline fundamentals include a market capitalization of $163 million, a price-to-earnings ratio of 12.23, and a dividend yield of 2.77%. CSB Bancorp has raised its dividend for 12 consecutive years. Those metrics accompany the recent share-price strength that has pushed CSBB toward its yearly high.

This filing reflects a modest, targeted purchase by a director rather than a large-scale accumulation. The quantity purchased and the dollar value involved are limited in absolute terms, but the transaction updates public records of insider activity and shows an incremental increase in the director’s reported direct holdings.

Investors tracking insider transactions and shareholder alignment will note the breakdown of Kirkbride’s ownership across direct, IRA, spousal IRA, and custodial accounts. The record shows both direct and indirect positions, with the reporting person disclaiming beneficial ownership as stated in the filing.

Given the company metrics, recent price appreciation, and the continued history of annual dividend increases, this disclosure adds to the public view of how insiders are positioned while the stock trades near its 52-week peak.

Risks

  • The director purchase is small in dollar value and share count, which limits its signal about material insider conviction for investors in the banking sector.
  • The stock is trading near its 52-week high, which may present valuation sensitivity and price volatility for holders in the regional banking and financials sectors.
  • Reporting person disclaims beneficial ownership, which may affect how the ownership stake is interpreted by other market participants.

More from Insider Trading

BKV Corp CFO Disposes $216,918 in Shares as Company Advances Public Offering Mar 27, 2026 Castellum Director Sells $21,129 in Stock as Company Posts Debt Retirement and Contract Gains Mar 27, 2026 Corcept CEO Sells $1.3M in Stock as Company Sees FDA Win and Legal Headwinds Mar 27, 2026 Arteris CEO Disposes $731,623 in Stock Across Two Trades Mar 27, 2026 Tecogen Director Adds $25,400 to Stake Amid Mixed Financial Signals Mar 27, 2026